デフォルト表紙
市場調査レポート
商品コード
1609074

低侵襲胸部外科手術市場:タイプ、技術、用途、エンドユーザー別-世界予測2025-2030年

Minimally Invasive Thoracic Surgery Market by Type (Lobectomy, Pleurectomy, Pneumonectomy), Technology (Laparoscopy Surgery, Medical Robotics, Non-Visual Imaging), Application, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
低侵襲胸部外科手術市場:タイプ、技術、用途、エンドユーザー別-世界予測2025-2030年
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

低侵襲胸部外科手術市場は、2023年に26億3,000万米ドルと評価され、2024年には27億3,000万米ドルに達すると予測され、CAGR 7.45%で成長し、2030年には43億6,000万米ドルになると予測されています。

低侵襲胸部外科手術(MITS)とは、開腹手術に伴う外傷、回復時間、合併症を軽減するために、小さな切開創と高度な技術を用いて胸部に行われる外科手術のことです。MITSの必要性は、肺および食道疾患の有病率の増加、高齢者人口の増加、より精密で苦痛の少ない手術方法に対する需要の増大から生じています。MITSは肺がん、食道がん、良性疾患の治療に用途があり、病院、専門クリニック、外科センターでの最終用途が多いです。市場に影響を与える主な成長要因としては、ロボット支援システムや画像技術の向上といった手術器具の技術的進歩に加え、ヘルスケア支出の増加、患者や医療提供者のメリットに関する意識の高まりが挙げられます。潜在的なビジネスチャンスは、より幅広い胸部疾患へのMITSの応用拡大や、インフラやヘルスケアへの投資拡大による新興市場での採用拡大という形で生じる。こうした機会を生かすための提言としては、より高度な技術の研究開発への投資、ヘルスケア機関との戦略的協力関係の構築、利害関係者を教育するための効果的なマーケティング戦略の実施などが挙げられます。しかし、機器の高コスト、規制当局の厳しい承認、熟練した専門家の不足といった制約が、市場成長にとって大きな課題となっています。さらに、認知度や信頼性の不足から、患者が新しい手術手技の採用に消極的であることも、市場拡大の妨げとなる可能性があります。技術革新の分野には、費用対効果の高いポータブル手術装置の開発や、人工知能を用いたロボット支援機能の強化などがあります。術後の転帰の改善、外科医向けのトレーニングプログラム、低リソース環境向けの拡張性ソリューションに焦点を当てた調査は、事業成長の道筋を示しています。MITS市場は、技術革新とヘルスケアニーズの進化に牽引されるダイナミックな市場であり、持続的な成長のためには継続的なイノベーションと適応が求められます。

主な市場の統計
基準年[2023] 26億3,000万米ドル
予測年[2024] 27億3,000万米ドル
予測年[2030] 43億6,000万米ドル
CAGR(%) 7.45%

市場力学:急速に進化する低侵襲胸部外科手術市場の主要市場インサイトを公開

低侵襲胸部外科手術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 慢性疾患の有病率の上昇と外科手術件数の増加
    • 低侵襲胸部手術に対する需要の高まり
    • 高齢者人口の増加と対象疾患に関する意識の高まり
  • 市場抑制要因
    • 手術費用の高さ
  • 市場機会
    • 狭帯域画像内視鏡やHDカメラなど、技術的に進んだ製品の入手可能性
    • 胸部外科分野における技術進歩のための研究開発投資の増加
  • 市場の課題
    • 訓練を受けた専門家の不足

ポーターのファイブフォース:低侵襲胸部外科手術市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:低侵襲胸部外科手術市場における外部からの影響の把握

外部マクロ環境要因は、低侵襲胸部外科手術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析低侵襲胸部外科手術市場における競合情勢の把握

低侵襲胸部外科手術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス低侵襲胸部外科手術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、低侵襲胸部外科手術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨低侵襲胸部外科手術市場における成功への道筋を描く

低侵襲胸部外科手術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の増加と外科手術の増加
      • 低侵襲胸部手術の需要増加
      • 高齢者人口の増加と対象疾患に関する意識の高まり
    • 抑制要因
      • 手続きにかかる費用が高い
    • 機会
      • 狭帯域イメージング内視鏡やHDカメラなどの技術的に高度な製品の提供
      • 胸部外科分野の技術進歩のための研究開発への投資増加
    • 課題
      • 訓練を受けた専門家の不足
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 低侵襲胸部外科手術市場:タイプ別

  • 肺葉切除術
  • 胸膜切除術
  • 肺切除術
  • 楔状切除

第7章 低侵襲胸部外科手術市場:技術別

  • 腹腔鏡手術
  • 医療ロボット
  • 非視覚イメージング
  • 経カテーテル手術

第8章 低侵襲胸部外科手術市場:用途別

  • 食道がん
  • 胃食道逆流症
  • 肺がん

第9章 低侵襲胸部外科手術市場:エンドユーザー別

  • 外来手術センター
  • 病院

第10章 南北アメリカの低侵襲胸部外科手術市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の低侵襲胸部外科手術市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの低侵襲胸部外科手術市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • B. Braun Melsungen, AG
  • Cook Group Incorporated
  • GE Healthcare Inc.
  • Grena Ltd.
  • Intuitive Surgical Inc
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Medela Inc.
  • Medtronic PLC
  • NuVasive, Inc.
  • Richard Wolf GmbH
  • Stryker Corporation
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. MINIMALLY INVASIVE THORACIC SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MINIMALLY INVASIVE THORACIC SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MINIMALLY INVASIVE THORACIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MINIMALLY INVASIVE THORACIC SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MINIMALLY INVASIVE THORACIC SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PLEURECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY PNEUMONECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY WEDGE RESECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LAPAROSCOPY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY MEDICAL ROBOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY NON-VISUAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TRANSCATHETER SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM MINIMALLY INVASIVE THORACIC SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. MINIMALLY INVASIVE THORACIC SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. MINIMALLY INVASIVE THORACIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-3A2E844FEF43

The Minimally Invasive Thoracic Surgery Market was valued at USD 2.63 billion in 2023, expected to reach USD 2.73 billion in 2024, and is projected to grow at a CAGR of 7.45%, to USD 4.36 billion by 2030.

Minimally Invasive Thoracic Surgery (MITS) refers to surgical procedures performed on the chest using small incisions and advanced technology to reduce trauma, recovery time, and complications associated with open surgeries. The necessity for MITS arises from the growing prevalence of lung and esophageal diseases, rising geriatric demographics, and augmented demand for more precise and less painful surgical options. MITS finds applications in treating lung cancer, esophageal cancer, and benign conditions, with significant end-use among hospitals, specialty clinics, and surgical centers. Key growth factors influencing the market include technological advancements in surgical instruments, such as robotic-assisted systems and improved imaging techniques, along with escalating healthcare expenditure and escalating awareness regarding benefits among patients and healthcare providers. Potential opportunities arise in the form of expanding applications of MITS to a broader range of thoracic conditions and increased adoption in emerging markets due to growing infrastructure and healthcare investments. Recommendations to capitalize on these opportunities include investment in R&D for more sophisticated technology, forging strategic collaborations with healthcare institutions, and implementing effective marketing strategies to educate stakeholders. However, limitations such as high costs of equipment, stringent regulatory approvals, and a dearth of skilled professionals pose significant challenges to market growth. Additionally, patient reluctance in adopting new surgical techniques due to a lack of awareness and trust can impede expansion. Innovation areas include developing cost-effective, portable surgical devices and enhancing robotic-assisted capabilities with artificial intelligence. Research focusing on improving post-operative outcomes, training programs for surgeons, and scalability solutions for low-resource settings presents avenues for business growth. The MITS market is dynamic, driven by technological breakthroughs and evolving healthcare needs, demanding continuous innovation and adaptation for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.63 billion
Estimated Year [2024] USD 2.73 billion
Forecast Year [2030] USD 4.36 billion
CAGR (%) 7.45%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minimally Invasive Thoracic Surgery Market

The Minimally Invasive Thoracic Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases and increased number of surgical procedures
    • Growing demand for minimally invasive thoracic surgeries
    • Increase in the geriatric population coupled with growing awareness regarding the target disorders
  • Market Restraints
    • High cost of the procedures
  • Market Opportunities
    • Availability of technologically advanced products, such as narrow-band imaging endoscopes, and HD cameras
    • Increasing investments in research and development for technological advancement in the field of thoracic surgeries
  • Market Challenges
    • Dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Minimally Invasive Thoracic Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minimally Invasive Thoracic Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minimally Invasive Thoracic Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minimally Invasive Thoracic Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minimally Invasive Thoracic Surgery Market

A detailed market share analysis in the Minimally Invasive Thoracic Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minimally Invasive Thoracic Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minimally Invasive Thoracic Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minimally Invasive Thoracic Surgery Market

A strategic analysis of the Minimally Invasive Thoracic Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Thoracic Surgery Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen, AG, Cook Group Incorporated, GE Healthcare Inc., Grena Ltd., Intuitive Surgical Inc, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medela Inc., Medtronic PLC, NuVasive, Inc., Richard Wolf GmbH, Stryker Corporation, Teleflex Incorporated, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Thoracic Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Lobectomy, Pleurectomy, Pneumonectomy, and Wedge Resection.
  • Based on Technology, market is studied across Laparoscopy Surgery, Medical Robotics, Non-Visual Imaging, and Transcatheter Surgery.
  • Based on Application, market is studied across Esophageal Cancer, Gastroesophageal Reflux, and Lung Cancer.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases and increased number of surgical procedures
      • 5.1.1.2. Growing demand for minimally invasive thoracic surgeries
      • 5.1.1.3. Increase in the geriatric population coupled with growing awareness regarding the target disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of technologically advanced products, such as narrow-band imaging endoscopes, and HD cameras
      • 5.1.3.2. Increasing investments in research and development for technological advancement in the field of thoracic surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minimally Invasive Thoracic Surgery Market, by Type

  • 6.1. Introduction
  • 6.2. Lobectomy
  • 6.3. Pleurectomy
  • 6.4. Pneumonectomy
  • 6.5. Wedge Resection

7. Minimally Invasive Thoracic Surgery Market, by Technology

  • 7.1. Introduction
  • 7.2. Laparoscopy Surgery
  • 7.3. Medical Robotics
  • 7.4. Non-Visual Imaging
  • 7.5. Transcatheter Surgery

8. Minimally Invasive Thoracic Surgery Market, by Application

  • 8.1. Introduction
  • 8.2. Esophageal Cancer
  • 8.3. Gastroesophageal Reflux
  • 8.4. Lung Cancer

9. Minimally Invasive Thoracic Surgery Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospital

10. Americas Minimally Invasive Thoracic Surgery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Minimally Invasive Thoracic Surgery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Minimally Invasive Thoracic Surgery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen, AG
  • 2. Cook Group Incorporated
  • 3. GE Healthcare Inc.
  • 4. Grena Ltd.
  • 5. Intuitive Surgical Inc
  • 6. Johnson & Johnson Services, Inc.
  • 7. Koninklijke Philips N.V.
  • 8. Medela Inc.
  • 9. Medtronic PLC
  • 10. NuVasive, Inc.
  • 11. Richard Wolf GmbH
  • 12. Stryker Corporation
  • 13. Teleflex Incorporated
  • 14. Zimmer Biomet Holdings, Inc.